Insider · CIK 0001242126

MCDADE MARK

Reports to the SEC for 10 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001242126

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-10-28	TRMLTourmaline Bio, Inc.U Disposition from Tender	Director	UDisposition from Tender	−518 sh	—	—	0
2025-10-28	TRMLTourmaline Bio, Inc.U Disposition from Tender	Director	UDisposition from Tender	−183K sh	—	—	0
2025-10-28	TRMLTourmaline Bio, Inc.U Disposition from Tender	Director	UDisposition from Tender	−110K sh	—	—	0
2025-10-28	TRMLTourmaline Bio, Inc.U Disposition from Tender	Director	UDisposition from Tender	−448K sh	—	—	0
2025-10-28	TRMLTourmaline Bio, Inc. · Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2025-10-28	TRMLTourmaline Bio, Inc. · Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2025-10-28	TRMLTourmaline Bio, Inc. · Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16.8K sh	—	—	0
2025-06-04	TRMLTourmaline Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16.8K sh	—	—	16,800
2024-06-05	TRMLTourmaline Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2024-02-19	Icosavax, Inc.U Disposition from Tender	See Remarks	UDisposition from Tender	−55.8K sh	—	—	0
2024-02-19	Icosavax, Inc.U Disposition from Tender	See Remarks	UDisposition from Tender	−3.51M sh	—	—	0
2024-02-19	Icosavax, Inc.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−22.3K sh	—	—	0
2024-02-19	Icosavax, Inc.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−17K sh	—	—	0
2024-01-29	TRMLTourmaline Bio, Inc.P Purchase	Director	PPurchase	+100K sh	$32.50	+$3.25M	448,431
2023-10-23	TRMLTourmaline Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2023-10-19	TRMLTourmaline Bio, Inc.A Award	Director	AAward	+348K sh	—	—	348,431
2023-10-19	TRMLTourmaline Bio, Inc.A Award	Director	AAward	+518 sh	—	—	518
2023-10-19	TRMLTourmaline Bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20.5K sh	—	—	0
2023-06-13	TRMLTourmaline Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20.5K sh	—	—	20,500
2023-06-06	Icosavax, Inc.Stock Option (Right to Buy)A Award	See Remarks	AAward	+17K sh	—	—	17,000
2022-06-10	Icosavax, Inc.A Award	See Remarks	AAward	+5,543 sh	—	—	55,786
2022-06-10	Icosavax, Inc.Stock Option (Right to Buy)A Award	See Remarks	AAward	+22.3K sh	—	—	22,278
2022-06-09	TRMLTourmaline Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.5K sh	—	—	14,501
2022-04-01	Icosavax, Inc.P Purchase	See Remarks	PPurchase	+42.2K sh	$7.10	+$300K	50,243
2020-10-13	Aimmune Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−7,840 sh	$34.50	−$270K	0
2020-10-13	Aimmune Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−105K sh	$31.48	−$3.3M	0
2020-10-13	Aimmune Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−19.8K sh	$19.10	−$377K	0
2020-10-13	Aimmune Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−17.5K sh	$16.24	−$284K	0
2020-10-13	Aimmune Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,500 sh	$1.71	−$12.8K	0
2020-10-13	Aimmune Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11.4K sh	$14.60	−$167K	0
2020-10-13	Aimmune Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15.4K sh	$17.39	−$268K	0
2020-10-10	Aimmune Therapeutics, Inc.U Disposition from Tender	Director	UDisposition from Tender	−26.9K sh	$34.50	−$926K	0
2020-05-27	Aimmune Therapeutics, Inc.A Award	Director	AAward	+7,840 sh	—	—	34,692
2020-05-27	Aimmune Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+15.4K sh	—	—	15,398
2020-02-20	Dermira, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−6,000 sh	$18.75	−$113K	0
2020-02-20	Dermira, Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−23.3K sh	—	—	0
2020-02-20	Dermira, Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,758 sh	—	—	0
2020-02-20	Dermira, Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10.3K sh	—	—	0
2020-02-20	Dermira, Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,000 sh	—	—	0
2020-02-20	Dermira, Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,000 sh	—	—	0
2020-02-20	Dermira, Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,000 sh	—	—	0
2020-02-20	Dermira, Inc.Restricted Stock UnitD Disposition to Issuer	Director	DDisposition to Issuer	−3,000 sh	—	—	0
2019-06-12	Dermira, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,000 sh	—	—	6,000
2019-06-12	Dermira, Inc.Common StockM Exercise/Conversion	Director	MExercise/Conversion	−3,000 sh	—	—	0
2019-06-04	Dermira, Inc.Director Stock Option (right to buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2019-06-04	Dermira, Inc.Restricted Stock UnitA Award	Director	AAward	+3,000 sh	—	—	3,000
2019-05-23	Aimmune Therapeutics, Inc.A Award	Director	AAward	+6,442 sh	—	—	26,852
2019-05-23	Aimmune Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+11.4K sh	—	—	11,432
2018-11-02	PHILLIPS EDISON GROCERY CENTER REIT II, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−6,464.555 sh	$22.54	−$146K	0
2018-08-07	PHILLIPS EDISON GROCERY CENTER REIT II, INC.A Award	Director	AAward	+1,097 sh	—	—	6,465

Recent filings

Accepted (ET)
Oct 284
MCDADE MARK0001242126-25-000005
SEC(opens sec.gov)
Jun 64
MCDADE MARK0001827506-25-000074
SEC(opens sec.gov)
Jun 74
MCDADE MARK0001827506-24-000055
SEC(opens sec.gov)
Feb 204
MCDADE MARK0000950170-24-017405
SEC(opens sec.gov)
Jan 314
MCDADE MARK0001415889-24-002069
SEC(opens sec.gov)
Oct 234
MCDADE MARK0001209191-23-053401
SEC(opens sec.gov)
Jun 144
MCDADE MARK0001209191-23-037186
SEC(opens sec.gov)
Jun 84
MCDADE MARK0001209191-23-035589
SEC(opens sec.gov)

Companies

Address

280 EAST GRAND AVENUE

SOUTH SAN FRANCISCO, CA, 94080